^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ADI-002

i
Other names: ADI-002, 41BBζ-sIL15 GPC3-CAR Vδ1 T cell therapy, GPC-3.sIL-15.CAR Vδ1 T cells, ADI 002, ADI002
Associations
Trials
Company:
Adicet Bio, Regeneron
Drug class:
γδ TCR modulator, IL-15R agonist, GPC-3-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials